Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 8—August 2020
Synopsis

Rise in Babesiosis Cases, Pennsylvania, USA, 2005–2018

David IngramComments to Author  and Tonya Crook
Author affiliations: Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA

Main Article

Figure 1

Counties where confirmed babesiosis cases were thought to have been acquired during 2011–2018 according to previous studies (2–4) compared with cases seen at Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA, during 2005–2018. Red triangles indicate cases from previous studies (not all cases shown); blue stars indicate cases seen at Hershey Medical Center.

Figure 1. Counties where confirmed babesiosis cases were thought to have been acquired during 2011–2018 according to previous studies (2–4) compared with cases seen at Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA, during 2005–2018. Red triangles indicate cases from previous studies (not all cases shown); blue stars indicate cases seen at Hershey Medical Center.

Main Article

References
  1. Vannier  E, Krause  PJ. Human babesiosis. N Engl J Med. 2012;366:2397–407. DOIPubMedGoogle Scholar
  2. Acosta  ME, Ender  PT, Smith  EM, Jahre  JA. Babesia microti infection, eastern Pennsylvania, USA. Emerg Infect Dis. 2013;19:1105–7. DOIPubMedGoogle Scholar
  3. Genda  J, Negron  EA, Lotfipour  M, Balabhadra  S, Desai  DS, Craft  DW, et al. Severe Babesia microti infection in an immunocompetent host in Pennsylvania. J Investig Med High Impact Case Rep. 2016;4:2324709616663774. DOIPubMedGoogle Scholar
  4. Liu  HH, Cushinotto  L, Giger  O, Daum  G, McBride  P, Negron  EA, et al. Increasing babesiosis in southeastern Pennsylvania, 2008–2017. Open Forum Infect Dis. 2019;6:ofz066. DOIPubMedGoogle Scholar
  5. Hatcher  JC, Greenberg  PD, Antique  J, Jimenez-Lucho  VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis. 2001;32:1117–25. DOIPubMedGoogle Scholar
  6. Mareedu  N, Schotthoefer  AM, Tompkins  J, Hall  MC, Fritsche  TR, Frost  HM. Risk factors for severe infection, hospitalization, and prolonged antimicrobial therapy in patients with babesiosis. Am J Trop Med Hyg. 2017;97:1218–25. DOIPubMedGoogle Scholar
  7. Young  C, Krause  PJ. The problem of transfusion-transmitted babesiosis. Transfusion. 2009;49:2548–50. DOIPubMedGoogle Scholar
  8. Levin  AE, Krause  PJ. Transfusion-transmitted babesiosis: is it time to screen the blood supply? Curr Opin Hematol. 2016;23:573–80. DOIPubMedGoogle Scholar
  9. Gray  EB, Herwaldt  BL. Babesiosis Surveillance - United States, 2011-2015. MMWR Surveill Summ. 2019;68(No. SS-6):1–11. DOIPubMedGoogle Scholar
  10. Hutchinson  ML, Strohecker  MD, Simmons  TW, Kyle  AD, Helwig  MW. Prevalence rates of Borrelia burgdorferi (Spirochaetales: Spirochaetaceae), Anaplasma phagocytophilum (Rickettsiales: Anaplasmataceae), and Babesia microti (Piroplasmida: Babesiidae) in host-seeking Ixodes scapularis (Acari: Ixodidae) from Pennsylvania. J Med Entomol. 2015;52:693–8. DOIPubMedGoogle Scholar
  11. Centers for Disease Control and Prevention. Babesiosis (Babesia spp.) 2011 case definition [cited 2020 Mar 5]. https://wwwn.cdc.gov/nndss/conditions/babesiosis/case-definition/2011
  12. Harris  PA, Taylor  R, Thielke  R, Payne  J, Gonzalez  N, Conde  JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81. DOIPubMedGoogle Scholar
  13. Menis  M, Forshee  RA, Kumar  S, McKean  S, Warnock  R, Izurieta  HS, et al. Babesiosis occurrence among the elderly in the United States, as recorded in large Medicare databases during 2006–2013. PLoS One. 2015;10:e0140332. DOIPubMedGoogle Scholar
  14. Herwaldt  BL, McGovern  PC, Gerwel  MP, Easton  RM, MacGregor  RR. Endemic babesiosis in another eastern state: New Jersey. Emerg Infect Dis. 2003;9:184–8. DOIPubMedGoogle Scholar
  15. Apostolou  A, Sorhage  F, Tan  C. Babesiosis surveillance, new jersey, USA, 2006-2011. Emerg Infect Dis. 2014;20:1407–9. DOIPubMedGoogle Scholar
  16. Filstein  MR, Benach  JL, White  DJ, Brody  BA, Goldman  WD, Bakal  CW, et al. Serosurvey for human babesiosis in New York. J Infect Dis. 1980;141:518–21. DOIPubMedGoogle Scholar
  17. Meldrum  SC, Birkhead  GS, White  DJ, Benach  JL, Morse  DL. Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis. 1992;15:1019–23. DOIPubMedGoogle Scholar
  18. Kogut  SJ, Thill  CD, Prusinski  MA, Lee  JH, Backerson  PB, Coleman  JL, et al. Babesia microti, upstate New York. Emerg Infect Dis. 2005;11:476–8. DOIPubMedGoogle Scholar
  19. Joseph  JT, Roy  SS, Shams  N, Visintainer  P, Nadelman  RB, Hosur  S, et al. Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis. 2011;17:843–7. DOIPubMedGoogle Scholar
  20. Linden  JV, Prusinski  MA, Crowder  LA, Tonnetti  L, Stramer  SL, Kessler  DA, et al. Transfusion-transmitted and community-acquired babesiosis in New York, 2004 to 2015. Transfusion. 2018;58:660–8. DOIPubMedGoogle Scholar
  21. Dunn  JM, Krause  PJ, Davis  S, Vannier  EG, Fitzpatrick  MC, Rollend  L, et al. Borrelia burgdorferi promotes the establishment of Babesia microti in the northeastern United States. PLoS One. 2014;9:e115494. DOIPubMedGoogle Scholar
  22. Dennis  DT, Nekomoto  TS, Victor  JC, Paul  WS, Piesman  J. Reported distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the United States. J Med Entomol. 1998;35:629–38. DOIPubMedGoogle Scholar
  23. Cherepko  J, Berry  GJ, Keeler  SP, Huffman  JE. Prevalence of Borrelia burgdorferi, Bartonella spp., Bartonella henselae, Babesia microti and Anaplasma phagocytophila in Ixodes scapularis ticks collected in Monroe County, Pennsylvania, show a risk for co- and tri-infections. J Pa Acad Sci. 2010;84:74–8.
  24. Fida  M, Challener  D, Hamdi  A, O’horo  J, Abu Saleh  O. Babesiosis: a retrospective review of 38 cases in the upper Midwest. Open Forum Infect Dis. 2019;6:ofz311. DOIPubMedGoogle Scholar
  25. Wormser  GP, Dattwyler  RJ, Shapiro  ED, Halperin  JJ, Steere  AC, Klempner  MS, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089–134. DOIPubMedGoogle Scholar
  26. Spaete  J, Patrozou  E, Rich  JD, Sweeney  JD. Red cell exchange transfusion for babesiosis in Rhode Island. J Clin Apher. 2009;24:97–105. DOIPubMedGoogle Scholar
  27. Saifee  NH, Krause  PJ, Wu  Y. Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both? J Clin Apher. 2016;31:454–8. DOIPubMedGoogle Scholar
  28. Nixon  CP, Park  S, Nixon  CE, Reece  RM, Sweeney  JD. Adjunctive treatment of clinically severe babesiosis with red blood cell exchange: a case series of nineteen patients. Transfusion. 2019;59:2629–35. DOIPubMedGoogle Scholar
  29. Krause  PJ, Telford  SR III, Spielman  A, Sikand  V, Ryan  R, Christianson  D, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA. 1996;275:1657–60. DOIPubMedGoogle Scholar
  30. Kletsova  EA, Spitzer  ED, Fries  BC, Marcos  LA. Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone. Ann Clin Microbiol Antimicrob. 2017;16:26. DOIPubMedGoogle Scholar

Main Article

Page created: June 08, 2020
Page updated: July 17, 2020
Page reviewed: July 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external